# A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

> **NCT07595549** · PHASE3 · RECRUITING · sponsor: **Pfizer** · enrollment: 954 (estimated)

## Conditions studied

- Obesity
- Overweight and/or Obesity
- Overweight

## Interventions

- **DRUG:** PF-08653944
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07595549
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-10
- **Primary completion:** 2028-05-04
- **Final completion:** 2028-06-21
- **Target enrollment:** 954 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07595549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07595549, "A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07595549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
